Fenofibrate may reduce heart disease risk in some patients with type 2 diabetes
Wednesday, December 28, 2016 - 21:41
in Health & Medicine
A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of 'good' cholesterol, despite being treated with statins.